chartexchange

BOLT
Bolt Biotherapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 17, 2026 3:59:31 PM EST
5.71USD-1.552%(-0.09)86,612
Pre-marketNov 17, 2026 8:52:30 AM EST
5.57USD-3.966%(-0.23)
After-hoursNov 17, 2026 4:34:30 PM EST
5.54USD-2.977%(-0.17)
4.7800Bid6.5800Ask1.8000Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Redwood City, CA, USA
Previous Close
$5.80
Beta
0.47
52-Week High
$7.78 2026-10-23
52-Week Low
$3.10 2026-09-18
SMA 50
$4.66
SMA 200
$4.50
Avg. Vol 10D
101,888
Avg. Vol 30D
510,978
Avg. Vol 90D
187,753
Relative Vol
0.15
1.64M
6.4300%
11,432
Jun 9, 2025 · 1-for-20 (reverse)
BOLT Profile

bolt biotherapeutics is a start-up with compelling technology from dr. engleman's lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company's future leaders to help it further develop and bring to patients novel and curative biotherapies.

BOLT Performance
PeriodPriceDateChangeBeta
1W6.302026-11-10-9.37%1.206
1M4.002026-10-16+42.75%-0.045
3M3.202026-08-17+78.44%0.520
6M4.362026-05-18+30.96%0.334
1Y4.512025-11-17+26.61%0.465
2Y11.182024-11-18-48.93%—
5Y180.202021-11-17-96.83%0.814
BOLT Stock Summary

Bolt Biotherapeutics, Inc. Common Stock (NASDAQ:BOLT) stock price today is $5.71, and today's volume is 78,815. BOLT is down 1.552% today. The 30 day average volume is 510,978. BOLT market cap is $13.46M with 2.36M shares outstanding.